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I. INTRODUCTION 
A. The Motor End Plate 
The motor end plate has been under investigation 
for nearly 137 years, thus predating the cellular theory 
of tissue organization. The concepts of the .junction of 
nerve and muscle have changed with the advance of knowledge 
in neurology and neuroanatomy and the development of newer 
techniques. The evolution of the modern concept of this 
important anatomic and physiologic junction can be traced 
from early studies, (49), 
The first published investigations are those of 
Valentin and Emmert in 1336. They described an "arc-like" 
ending of the motor nerve at the muscle, and concluded that 
the motor nerve progressed from the central nervous system 
to the muscle, continued around the arc, and then returned 
to the central nervous system. They postulated a continuous 
stream of "nervous fluid" in the motor nerve. 
Doyere in 1840 was the first to propose that the 
motor nerve came to a complete end at the muscle. This was 
confirmed in 1843 by Quartrefages and by Wagner in 1847, who 
also noted that the myelin sheath of the nerve was lost 
shortly before its entry into the muscle. 
No more advances were made until 1862 when Kuhne, 
using gold staining, showed branching and complete arboriza¬ 
tion at the nerve terminal. In the same year, Rouget 
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demonstrated a heap of granules at the nerve terminal, and 
recognized the specialized nature of the neuromuscular junc¬ 
tion. 
Ranvier, in 1878, began using a gold impregnation 
technique, and just after the turn of the century, Cajal 
and others introduced the still-used silver staining tech¬ 
nique. In 1863> Krause first used the term "motorische end 
plate1' in his studies of the cat eye retractor muscle. 
The first descriptions of the motor end plate are 
those obtained with gold impregnation. These show terminal 
nerve endings and some fringe-like structures. Silver stain¬ 
ing (of which there are a number of techniques) reveals the 
more delicate structure of the neurofibrils, boutons ter- 
mineaux, and granules at the nerve endings. The chemical 
nature of the reaction is not known, but a silver-protein 
complex is proposed. Methylene blue has been used to elu¬ 
cidate the structure of the motor end plates. Staining with 
it reveals terminal axons with arborizations, and some other 
structures, but again the nature of the reaction is not 
known. Numerous descriptions of fine detail of motor end 
plate structures are available, all somewhat dependent on 
the technique used. The advent of the electron microscope 
has allowed study of even finer structural detail (4), With 
this tool, the details of the anatomic interrelation of nerve 
and muscle are being seen. 
olun1c q.<:srl £ bsl.e'iiteiioaief) 
• ssllsioeqe snl JbasXnsc os 2 
. 
j A07 £ r a Xeu rsugscf «• ’81 rci /isXvxijbS 
• i .g ■ r 1 e lou; 6ub t eupir::ce& 
* 
.. IXiute sJtxl tsl M s*t.slq 
oil to ' rioliql'iOQ&b Saifl srtT 
■ ■ ' :- ■ 
• •'• 3 9 fl ■' ' ■' 
t - riB snsttf dolciw lo) gixX 
■ rou'z&ii zf&otleb siocc 
. - 
;jjo ..../or:.-' ''or at nolloB9i ed:> lo piujbh 
. . 
. OUlCfSi 9X1 it ©d\BOiO 
J larxsit 8IB9V9T XX 
; jb itucf bs'iuXouiXb 
. 
'I.', t*^Xc BilBVB 9':u- ss'iuXoincXe sXelq 
- 
• 11 n?.V9 1 c TjJbuXs JbsvroIlB 8&xl 
e-r[rt lo plletsl 9iiX < loot a IriX 
.' : 
3 
Motor end plates are not distributed randomly among 
muscle fibers, but rather are distributed in well-localized 
bands, usually near the middle of the muscle (Figure 1). 
Commonly there is only one end plate per muscle fiber, al¬ 
though about 2,~5% of fibers in normal human muscle have two 
end plates (9> 10). These are most commonly from the same 
nerve fiber or the result of terminal branching. Occasion¬ 
ally one end plate is supplied by two different nerve fibers. 
One end plate supplied by two different axons has not been 
observed (49). 
There is a variation in shape and size of the motor 
end plate from muscle to muscle in the same animal and among 
different animals. The variations in end plate size seem to 
parallel the variation in muscle fiber size within a given 
muscle (10). Slow reacting ("red") muscles have larger end 
plates (10). 
In addition to descriptions of normal muscle, many 
changes in the diseased muscle have been described using all 
of the techniques mentioned. The three principal pathologic 
changes are: 
1. change in end plate size 
2. degenerative changes in fibers and endings 
3« reactive sprouting of nerve endings 
The change in the size of the end plate follows the 
change in the size of the muscle fiber. Immature end plates 
may be larger or smaller than normal. In thyrotoxic myopathy 
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the formation of multiple end plates on one muscle fiber 
occurs. There are well-formed but enlarged motor end plates 
in upper motor neuron disease (10). 
All of the early work, of course, focused on the 
anatomy of the motor end plate, and studies of the function 
awaited the development of more refined biochemical tools. 
Loewi’s discovery of *'vagusstuffH began the study of 
neurohumoral transmitters. Then, in 1926, Loewi demonstrated 
an enzyme which destroyed the "vagusstuff" he had earlier 
discovered. 
In 1940, Couteauz and Nachmannsohn demonstrated a 
correlation between the number of end plates in a given mus¬ 
cle and the amount of Loewi’s enzyme, acetylocholinesterase, 
as demonstrated by mierochemical techniques. Nachmannsohn 
also showed that the acetylcholinesterase present at the mo¬ 
tor end plate in frog muscle was enough to destroy the cal¬ 
culated amount of acetylocholine during the refractory period 
of the muscle. He followed this with the microchemical demon¬ 
stration that the highest concentration of acetylcholinesterase 
present In the muscle was in the motor end plate region (49)* 
Histochemical methods for localization of this enzyme 
in motor end plates have been developed. These will be dis¬ 
cussed in detail later. 
Thus the foundations for the synaptic theory of the 
function of the motor end plate were laid. The anatomic struc¬ 
ture was demonstrated, although incompletely. A physiologic 
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role for acetylcholine (Figure 2) as the biochemical trans¬ 
mitter, and acetylcholinesterase as the destructive enzyme 
was suggested. The theory could then be proposed that acti¬ 
vity in the motor nerve somehow resulted in the production 
of a compound (acetylcholine) at the nerve terminal which 
in turn stimulated the muscle on the other side of the junc¬ 
tion to activity. An enzyme to destroy the acetylcholine 
was present, and thus its action could be terminated. 
Acetylcholine depolarizes a receptor substance on the mus¬ 
cle side of the myoneural junction. The depolarization is 
brief, for the action of acetylcholinesterase is rapid. 
The receptor substance is generally thought to be an anionic 
receptor for the cationic head of acetylcholine, and an 
esteratic site for the acetyl group of acetylcholine. 
B. Hereditary Myopathy in the Mouse 
In 1955, Michelson, et al, described a strain of 
mice discovered at the Jackson laboratory, which was appar¬ 
ently an inbreeding mutation. These mice showed the clinical 
appearance of a kind of muscular dystrophy (35)* Their 
clinical course was characterized by progressive ataxia, 
atrophy, and paralysis, along with subnormal weight. The 
posterior limbs were most affected. A kyphosis resulting 
from the procession of the atrophy and paralysis was seen. 
The animals were cachectic and died at an early age, usually 
between one and six months. 
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The microscopic studies done, failed to reveal any 
lesions in the central or peripheral nervous systems. 
Pathological changes were found only in muscle. 
later studies of the histopathology in these mice 
agreed with the findings described by Michelson and showed 
that although there was some variability among animals, 
certain lesions were common to all (45). 
The major lesions seen were a variation in muscle 
fiber size, increase In endomysial connective tissue, go- 
agulation necrosis of muscle fiber, subsarcolemmic nuclear 
accumulations, internal nuclear rowing and regenerative 
activity. There was an equal incidence of disease in the 
flexors and the extensors. Lesions in smooth and cardiac 
muscle were not seen. Ho sex differences were noted. On 
cross section of muscle, a variation in muscle fiber dia- 
meter was the most distinct change. There was a tendency 
toward rounding of the fibers. 
There was much evidence for regeneration: nuclear 
rowing with large amounts of RNA, indicating anabolic acti- 
vity, and the presence of myoblast-like cells. Hypertrophy 
of fibers was seen, but not swelling. 
Other possible causes for nuclear rowing should be 
mentioned. Among them are failure to mature, atrophy or 
dedifferentiation, regenerative activity, reparative reac¬ 
tion to sublethal injury. 
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The mice are the result of an inbreeding mutation in 
the Jackson laboratory strain 129* Inheritance of the di¬ 
sease follows the pattern of an autosomal recessive (41, 45)* 
The genetics have been studied by an unusual method of breed¬ 
ing which was developed because the female mice are not 
healthy enough to carry many pregnancies. Breeding is ac¬ 
complished by ovarian transplant. The operation is done by 
grafting one half of the donor (dystrophic) ovary into the 
capsule of one of the recipient's ovaries after removal of 
both of the recipient's ovaries. Fertility following surgery 
is good and the healthy females are well able to carry sev¬ 
eral pregnancies. 
Strain 129/Re- +dy is the subline of strain 129 in 
which the mutation arose. There are three genetic classes 
of animals from non-sibling matings of 129/Re- +dy animals: 
1. dydy -- dystrophic animals 
2. Dydy -- non-dystrophic carriers 
3« Dydy -- either from carrier matings or from 
subline 129/J. All are non-dystrophic, 
non-carrier animals, and are used as 
controls in studies of the disease. 
No close association of age or weight of animals with 
gross symptoms of dystrophy could be found (44). 
A number of studies of the chemical constituents of 
dystrophic muscle as compared to normal muscle have been done. 
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There is increased lipid (34) along with decreased protein, 
decreased nitrogen, and increased collagen per gram of dry 
weight (44). Decreased creatinine has been reported by 
Kandeutsch, et al (27). Phospholipid concentration is the 
same in dystrophies as normal (48). Study of electrolyte 
concentration in muscle (2, 48) has revealed increased so¬ 
dium and decreased potassium except for normal potassium 
in cardiac muscle. 
Electrical profiles of normal and dystrophic muscle, 
in order to study fiber size and resting potential, have 
been done (28). These have shown that there is more vari¬ 
ation in fiber size in the dystrophic than in the normal 
muscle as well as more variation in resting potential. 
Resting potential is well correlated with fiber size in 
small fibers. There is more extracellular space in dystro¬ 
phic muscle. The mean fiber size is twice normal. 
The bioelectric properties of dystrophic muscle were 
studied by Conrad and Glaser (13). They found no signifi¬ 
cant difference in resting potential of excitable fibers, 
but a lower average resting potential in dystrophic muscle. 
Dystrophic muscle had multiple action potentials both spon¬ 
taneously and in response to stimulation. It also showed 
increased excitability. The increase in resting potential 
following reduction of the potassium concentration around 
the muscle was greater in the dystrophies than in the nor¬ 
mals. This is interesting in view of the known decrease in 
potassium concentration in dystrophic muscle. 
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Multiple action potentials were more frequent in the 
low potassium environment. 
Conrad and Glaser studied the miniature end plate 
potentials (mepp) at the myoneural junction in dystrophic 
muscle. These potentials occur at the motor end plate, and 
seem to be sub-threshold activity caused by spontaneous 
depolarization of nerve endings or release of acetylcholine. 
They found that the rate of miniature end plate potential 
production was decreased in dystrophic diaphragm and that 
the response to hypertonic saline was absent. The decay con¬ 
stant of the mepp is longer in dystrophic muscle, but the 
amplitude of the mepp was not abnormal. 
Studies of fatigue in dystrophic muscle indicate a 
change in transmission of nerve impulses to muscle. Te¬ 
tanic stimulation leads to a longer tension response and a 
longer action potential response. Single shock stimulation 
leads to a tetanic response, a longer decay period, but less 
tension (14). 
Baker et al have shorn that neostigmine induces tre¬ 
mors and increases existing tremors In dystrophic mice. A 
resistance to curare was also noted by them in these mice (3). 
Electron microscopic studies have revealed some changes 
in fine structure in dystrophic mouse muscle (39). Mito¬ 
chondria are swollen and have a denser matrix. The endo¬ 
plasmic reticulum is swollen and vacuolization is followed 
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by destruction. Myofibrils are destroyed. These changes 
start at random sites. There is no change in the sarco- 
1 ennuic membrane. The Z-band is intact, which differs from 
what is seen in an ischemic lesion. There is no apparent 
change in nuclear fine structure. 
Metabolic enzyme concentrations have been determined 
by homogenization techniques per gram of dry weight and per 
gram of protein nitrogen (44). Cytochrome oxidase is in¬ 
creased as are the other respiratory enzymes. The glycolytic 
enzymes remain unchanged. These latter two changes are the 
opposite of those seen after nerve section. The cathepsins 
are increased, as they are in any form of muscle wasting. 
Studies done on lyophilized muscle in which enzyme 
concentration was determined by the fluorescence of the 
oxidized or reduced pyridine nucleotide revealed a increase 
in the activity of enzymes requiring TPN, add a decrease in 
enzymes requiring DPN. 
The dystrophic strain of mice offers a model of hu¬ 
man dystrophy available for study. This is important be¬ 
cause it is difficult to do properly controlled studies of 
human patients with the disease. The mice offer an oppor¬ 
tunity for controlled genetic studies, investigation of 
muscle biochemistry, physiology and microanatomy. Studies 
in mice may lead to fruitful avenues of investigation in the 
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human disease. Histological comparisons between mouse 
dystrophy, Duchenne type dystrophy and human myotomic 
dystrophy, which the murine disease resemble clinically, 
have been made by Pearce and Walton (50). 
Necrosis of muscle fibers occurs to the same moderate 
degree in mice as it does in myotonic dystrophy, and it is 
not as extensive as in the Duchenne types. Fiber enlarge¬ 
ment is not as prominent in mice as in Duchenne dystrophy, 
but again resembles myotonic dystrophy. 
Centralization of nuclei occurs in mouse dystrophy 
as in myotonic dystrophy, and it is absent in Duchenne dys¬ 
trophy. This trend is opposite to that of prominent nucle¬ 
oli, which is common to murine dystrophy and Duchenne dys¬ 
trophy and rare in myotonic dystrophy. Nuclear chains only 
occur in the murine disease. Sarcoplasmic baslophilia and 
regenerative phenomena, common to mouse dystrophy and 
Duchenne dystrophy, are absent in myotonic dystrophy. The 
increase in fat and connective tissue resembles myotonic 
dystrophy. 
The number of similarities between mouse dystrophy 
and human disease, particularly myotonic dystrophy point 
to the usefulness of studying the animal disease with a 
view toward elucidation of human disease. Obviously, how¬ 
ever, the fact that mouse dystrophy is a separate disease 
taking place in animals must not be forgotten. It cannot 
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be assumed that any data found in mice apply directly to 
human disease, but only that the mice can serve as a model 
on which to base theories of human disease. 
C. Effects of Denervation 
Changes in both structure and enzyme concentration 
have been described in muscle following denervation. The 
first changes noted are in the motor end plates (22). This 
takes the form of shrinking and breaking up of end plates 
(9, 10). The changes appear after the degeneration of the 
nerve endings. Vacuoles begin to appear in the Schwann 
cells. If innervation is not re-established, atrophy of 
the muscle fiber with shrinking and fragmentation of the 
motor end plate and increased connective tissue results. 
Enzymes of the phosphatase group have been reported 
as increased by Golarz and Bourne (19)• They found in¬ 
crease in phosphatase activity histochemically. 
There has been much disagreement in the literature 
about the changes in acetylcholinesterase. Goers and Wolf 
(9) found that cholinesterase persists for a while and then 
staining becomes paler and irregular. Microchemical tech¬ 
niques reported by Nachmannsohn (22) indicate increases 
in cholinesterase. This is calculated per gram of muscle, 
however, and therefore does not take atrophy into account. 
Others have reported both increases and decreases, depend¬ 
ing on the techniques used (22). Snell and McIntyre (40) 
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found, using the Koelle-Friedenwald technique that cholin¬ 
esterase gradually disappeared after denervation. There 
■was a continued decrease with time until after 45 days 
there was none left. Stoerck and Morpeth (reported in 40) 
extracted whole denervated muscle and did manometric deter¬ 
minations of acetylcholinesterase and found a reduction by 
one-third, but this did not vary with time. 
D. Anticholinesterase Drugs 
A number of drugs are known which chemically inhibit 
acetylcholinesterase. Their action on enzyme activity as 
demonstrated histochemically is not known. 
One such drug is a long-acting anticholinesterase, 
BO-51* BC-51 is structurally two mestinon molecules linked 
by a hexamethylene bridge (Figure 3)* It was orig nally 
introduced by Kraupp (23) and has been used in the treat¬ 
ment of myasthenia gravis (43). 
The clinical pharmacology was studied by Kraupp et 
al (23) in rats. The duration of action was found to be 
72 hours. The intravenous ED^q for the production of 
bloody tears was 75*8 micrograms per kilogram; the SD^q 
for weakness was 52.4 mierograms per kilogram. For weak¬ 
ness in all animals, 100 micrograms per kilogram given in¬ 
travenously was required. The LD^q, given intravenously, 
in rats, was found to be 607 micrograms per kilogram. 
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II. METHODS AND EXPERIMENTAL DESIGN 
A. Design 
There are a number of reasons why it seemed worth¬ 
while to study the myoneural junction in this strain of 
mice. The changes in excitability of muscle and miniature 
end plate activity suggest that there may be something 
wrong with the transmission of nerve impulses to the mus¬ 
cle, as does the hypersensitivity to neostigmine and the 
resistance to curare. The anatomic changes in the muscle 
are not precisely those of denervation, nor are they pre¬ 
cisely those of primary myopathy. It seemed interesting 
therefore, to study the acetylcholinesterase activity at 
the myoneural junction in these animals as an anatomic 
parameter of the nerve to muscle transmission. 
It also seemed interesting to study the myoneural 
junction in denervated mouse muscle, and muscle from mice 
treated with anticholinesterase medication. These provide 
known anatomical and physiological lesions to study. A 
histochemical method was utilized to study the acetyl¬ 
cholinesterase activity at the myoneural junction in all 
three types of animals: dystophic, denervated, and drug 
recipient. 
The problem of histochemical localization in general 
is an interesting one. The basis for histochemistry is a 
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chemical reaction of a substrate at the enzyme site which 
forms, in a soluble phase, a chemical moiety which will 
then react with another reagent to form an insoluble pro¬ 
duct at the enzyme site. This product is preferably colored 
so that it can be visualized by light microscopy. Tech¬ 
niques for electron microscopy must be modified in order 
to obtain reaction products that are electron dense. 
The precision and accuracy of the technique depends 
on a number of factors. A physiologic substrate is of 
course, preferred. Diffusion of the end product leads to 
imprecise localization. This is best prevented by a tech¬ 
nique in which a rapid reaction leads to an insoluble pro¬ 
duct. Precision is also increased with encreasing size of 
the enzymatic site. If the reagent reacting with the stain 
precursor is used in large quantity and the capture reac¬ 
tion is a first order reaction kinetically, better locali¬ 
zation will result (20). 
It is useful to have a reaction which is suitable 
for frozen section technique. Better preservation of fine 
structure is usally a result of frozen section. In addition, 
many fixatives destroy enzymes, and preservation of enzyme 
integrity is a requisite to good histochemical technique. 
Histochemical interpretation is difficult and misleading if 
the nature of the chemical reactions involved is unknown. 
Similarly, non-specific reactions lead to mistaken inter¬ 
pretation of histochemical results. 
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The general priciples of histochemistry can be applied 
to the specific case of the localization of acetylcholinester¬ 
ase. Formalin inactivates the enzyme (24), and so it must 
be used cautiously if at all, even though it may give good 
histological results. The reactions of this enzyme are pH 
dependent (24), and pH changes may lead to erroneous results. 
Cholinesterase is however, well preserved in freezing tech¬ 
niques, and so cryostat sections are useful. 
The specificity of esterases is largely dependent on 
the length of the hydrocarbon chain on either side of the 
ester linkage. (16). Adams and Whitaker (reported in 16) 
showed that acetylcholinesterase will hydrolyze choline and 
non-choline esters. The rate decreases sharply with the 
addition of chains longer than acetyl. The shape of the 
molecule is more important than the presence or absence of 
a quaternary ammonium. Cholinesterase is more specific for 
choline esters than is acetylcholinesterase. Acetylcholin¬ 
esterase hydrolyzes analogues nearly twice as fast as does 
non-specific cholinesterase. 
Several techniques for localizing cholinesterases 
have been described. Early techniques utilized high mole¬ 
cular weight esters of choline and hydrolysis of these was 
not complete. These techniques demonstrated non-specific 
cholinesterases (49). The Koelle-Friedenwald technique (31) 
utilized acetylthiocholine as a substrate. The end product 
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however, was a coarse, granular, slightly soluble precipitate. 
This had the disadvantage of relatively high diffusability, 
and its coarse granularity made microscopic resolution rather 
poor. Other techniques that were developed (49) had the pro¬ 
blem of a substrate that was not specific for the enzyme. 
Some had end products that were such large crystals that they 
interferred with cytologic localization. 
In 1951, some physicochemical studies by Wilson (47) 
formed the background work for a histochemical technique 
later developed by Bari-nett and Palade (5)* Wilson was study¬ 
ing the mechanism of hydrolysis of esters by acetylcholin¬ 
esterase. He was using thioacetic acid (OH^GOSH) as a sub¬ 
strate for enzymatic hydrolysis. The reaction consists of 
acetylation of the enzyme with the simultaneous release of 
H2S. The acetylated enzyme then reacts with water to reform 
the enzyme and produce acetic acid. It is thus, the enzymatic 
hydrolysis of thioacetic acid. It is analogous to the en¬ 
zymatic hydrolysis of acetylcholine. The reaction is very 
much pH dependent. Decreasing pH increases the amount of 
uncissociated substrate (since it is a weak acid). The rate 
of the reaction increases with increasing undissociated sub¬ 
strate, since it is undissociated substrate that can react 
with the enzyme. However, enzyme activity was shown to de¬ 
crease with decreasing pH. Therefore, the reaction must be 
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studied at an optimum pH - one low enough that the concen¬ 
tration of undissociated substrate is fairly high, but not 
no low that the enzyme is destroyed. Wilson also found 
that prostigmine inhibited this reaction completely. 
The reaction was adapted for histochemical use and 
reported by Barrnett and Palade (5) in 1959. This tech¬ 
nique utilizes thioacetic as a substrate for enzyme activity. 
In the presence of lead nitrate, the liberated H2S reacts 
with the lead to form a black lead sulfide precipitate at 
the site of the enzyme activity. The reaction product, PbS, 
is a fine, black precipitate which is easily seen and does 
not disturb cellular detail. It is a heavy, insoluble pro¬ 
duct which does not aasily diffuse. The technique when 
first used was employed to study enzyme activity at the 
M-band in striated muscle. These deposits are too small 
to be seen by the light microscope. The technique does, 
however allow visualization of the motor end plate by light 
microscopy and comparison of structure and distribution in 
normal and experimental animals. 
The reaction does not take place in the presence of 
compounds known to inhibit the activity of the enzyme. Two 
kinds of enzyme inhibition have been described (33). Com¬ 
petitive inhibition is inhibition of enzyme activity by a 
compound that reacts in a reversible reaction to form an 
enzyme-inhibitor complex. There is competition between the 
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substrate and inhibitor for active enzyme sites. This is 
dependent on the concentration of inhibitor and of substrate. 
Inhibition may be overcome by the addition of high concen¬ 
trations of substrate. The amount of inhibition is de¬ 
pendent on substrate concentration if enzyme concentration 
is constant. 
In non-competitive inhibition, only the concentration 
of inhibitor is related to the amount of inhibition. The 
formation of enzyme-substrate complex does not take place 
at the site of enzyme activity, but at a site which renders 
the enzyme inactive. The reaction is not reversible. 
The two most common types of acetylcholinesterase 
inhibitors are the structural analogues of acetylcholine, 
and the organophosphorus derivatives. The structural ana¬ 
logues are adsorbed on both the anionic and esteratic sites 
of the enzyme. The organophosphorus compounds are only 
adsorbed at the esteratic site. The structural analogues 
act completely as competitive inhibitors. The organo¬ 
phosphorus inhibitors seem to act in two steps. The first 
is thought to be competitive in nature, but the second is 
irreversible. 
In this work, physostigmine, a competitive struc¬ 
tural analogue of acetylcholine was used. Physostigmine 
(Figure 4) is an ancient drug first obtained from the 
calabar bean which grows in Nigeria. It has been synthe¬ 
sized. Enzyme activity was studied in this work by varying 
. 'jol *xocr bns sd-sacredi/a 
'lOolJlrfai lo aolSK'itxQoaoo eiit no crasfcnsqsb 
id$ yd s&ooievo sor aal&Xdldsxl 
' 
r t )i& i vs'v j oroo-non nI 
r C 
•• j: *xc! d/ a-o/irr^ns lo rrc.id-, vr .. 
o.r.v.fcd'O-3 scr xns lo scris 9rd d-s 
. 
: r- ,-| . uOri.(iLC‘0 32 013 owe* Sift 
. .s*xi/1o.uto i.; s :1d s' s e*io<i.: ci i in_c 
. 
r oi.ioi.j •; ~v 'led no iiscfio? &. 9is ae- :--oi 
• ; .i - 
. 
. fo id ROD 8 1- 
icf i * 31. exnoi qe oifq 
.. ‘ii i 
. 
■ 30; 
. '• 
* ■ i a 
inhibitor concentrations at known, constant substrate 
concentrations. 
20 
The basic histological and histochemical techniques 
used were common to most of the animals. 
B. Dystrophic Mice 
The dystrophic animals studied were dystrophic 
and littermate controls of the Bar Harbor strain 129 (Dydy), 
obtained from the Roscoe B. Jackson Memorial Laboratory, 
Bar Harbor,Maine. 
0. Denervated Mice 
The denervated muscle studied was obtained from 
white Swiss laboratory mice. Under ether and nembutal 
anesthesia, the left sciatic nerve was identified under 
the gluteus maximus muscle near the point where it leaves 
the pelvis. Stimulation of this nerve led to movement of 
the left leg, thus aiding in its identification. The 
nerve was ligated with black silk, divided, and several 
millimeters were removed to prevent regrowth. The wound 
was closed with black silk. Limp and foot drop were im¬ 
mediately noted on the affected side. Atrophy occurred 
within one or two weeks on the affected side. The mice 
were studied seven to eight weeks after denervation. The 
unoperated leg was always studied simultaneously as a con¬ 
trol. 
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D. Drug Recipient Animals 
BO-51, a long acting anticholinesterase was kindly 
supplied by Dr. Paul Hoefer of Columbia University College 
of Physicians and Surgeons. It was diluted from a solution 
of Img/ml to a solution of 0.2 gm/ml and resterilized. It 
has been shown to be heat stable. 
Two groups of Sprague-Dawley rats were studied. One 
group was treated every 72 hours with BC-51> O.lmg/kg given 
intramuscularly. The other group was treated with an equi¬ 
valent volume of normal saline in the same way. The animals 
were studied at several week intervals. One animal was 
given a lethal overdose (1.2 mg/kg) to demonstrate the ef¬ 
ficacy of the drug. The animal succumbed in a typical 
cholinergic crisis five hours after the drug was given, 
with convulsions, profuse diaphoresis, salivation, respira¬ 
tory distress, bloody tears, and cardiac arrest. 
Normal Swiss laboratory mice and denervated mice 
were also given BC-51, O.lmg/kg, intramuscularly every 72 
hours. They were studies after seven and eight weeks of 
treatment. 
The animals were sacrificed by mild etherization 
followed by cervical fracture until ether was shown not 
to affect the results even when used in lethal quantities. 
Thereafter ether alone was used. 
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E. Histological Techniques 
Tibialis anticus muscle was studied in all cases, 
and was dissected from the leg immediately after sacrifice. 
In the early studies the dissected muscles were tied to 
plastic rectangles with surgical silk in order to prevent 
shrinkage and fixed for eight to ten hours, in cold 10% 
Formalin in 0.1 M Sorenson's phosphate buffer (11, 36) at 
pH 7*4 containing 0.4 M sucrose. The sucrose was used to 
raise the osmolar concentration of the medium and thereby 
preserve the fine structure of the muscle fibers (5)- The 
histochemical reaction was carried out, and then the muscle 
was sectioned at 20-50u on an A/0 Spencer freezing micro¬ 
tome, and stained in the usual way with hematoxylin and 
eosin. Later studies were carried out without fixation 
prior to the histochemical reaction. These muscles were 
rapidly frozen in small pieces in liquid nitrogen and sec¬ 
tioned at 8u with the Slee cryostat. After the histochem¬ 
ical reaction was done, the sections were fixed while on 
coverslips in 10% Formalin for severals hours, then stained 
with hematoxylin© and eosin and mounted on glass slides. 
End plates were measured with a Carl Zeiss eyepiece micro¬ 
meter calibrated with a Bausch and Lomb stage calibrator. 
F. Histochemical Techniques 
The histotchemical localization was carried out by 
the method described by Barrnett (5) in the following way. 
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Thioacetic acid (Eastman) 0.25ml, was titrated to 
pH 6.4 with 1.0 and 0.1N NaOH (Mallinckrodt). The pH 
determinations were originally done with a Beckman Model 
180 pH meter, and later with a Corning pH meter, which 
proved to be more accurate. The volume was then adjusted 
to 20ml. with sodium cacodylate buffer mads to pH 6.4 (38). 
Then 48 mg. of Pb(N0^)2 (Mallinckrodt) in 5 ml* of ca¬ 
codylate buffer were added slowly with stirring to complete 
the incubation solution. The pH was rigidly measured, 
because above pH 6.8 slow spontaneous hydrolysis of the 
substrate occurs, and at pH 7*4 it occurs at an appreci¬ 
able rate. Low pH of course, destroys the enzyme. When 
whole muscle was used, the reaction was observed with a 
dissecting microscope. Control and experimental muscle 
were always done together under identical conditions. 
Muscles were studied using the same incubation time, and 
also varying the time until the experimental end plates 
reached the same darkness as the controls, as observed 
under the dissecting microscope. 
It has been shown by Barrnett (4, 5) that the 
reaction does not occur without the substrate. 
G. Inhibition Studies 
Inhibition studies were done using solutions of 
physostigmine salicylate (Mallinckrodt) in varying con¬ 
centrations. The whole muscle was incubated in inhibitor 
for fifteen minutes, the sections for twenty minutes. 
Control and experimental muscle, inhibited and non-inhi- 
rfii-r^O 6T9W £ .-301tB&liTldt&b 
. 3" 
... 
■ 
- , :_-.c r. , . T£\- ;'c :ii ~ Ixboc 
■ 
. 
. 
o 1c • 
iJo£si siW tbezu saw sloeflta elorfw 
■ * .: oa 
. . 
. * - JE>9ifrJJ^:8 9*39W seloai/M 
,alo'ionoo 3:'v :a zi 3 infra b aiaae b>'.& bedoBs'i 
# 
. ■) \o rrwonfc &9Qd aar! ■tl 
# 
nolttdhinl 
' 
• i". 
3cvJtci I , £U!C '.■■tfr.r fi9qxs baa lott^noO 
24 
bited, were all run simultaneously. During incubation 
of the inhibited tissues, the reaction solution contained 
the same concentration of inhibitor as did the inhibiting 
solution. This maneuver was used because physostigmine 
is known to be a competitive inhibitor. 
III. RESULTS 
A. Dystrophic Mice 
Dystrophic muscle shows the classical character¬ 
istics as described by Michelson. The muscle fiber size 
varies greatly, there is coagulation necrosis, nuclear 
rowing, and increased connective tissue. The end plates 
vary in shape and appear "motheaten”. 
In the whole muscle studies, after incubation for 
the same length of time, end plates appeared to be much 
lighter. It took 1.5 times as long for them to achieve 
the same darkness as the controls. The normal pattern of 
distribution was not obvious. However, derangement of the 
fibers with coagulation necrosis occurs, and the absence 
of the pattern may well be due to this. In the normal 
muscle, the size of the end plates follows a normal dis- 
tribution curve. In the dystrophic muscle, however, there 
seems to be two populations of end plates: one of end 
plates the same size as the normals, and one of end plates 
more than twice the size of normals (figure 5)» 
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When a concentration of 1x10”5m Physostigmine was 
used for inhibition, no end plates were seen in either 
the normal or the dystrophic muscle. In all cases of nor¬ 
mal and dystrophic muscle run simultaneously without in¬ 
hibitor, end plates were seen. 
When the reaction was done in the presence of a 
physostigmine concentration of 1x10“7m, the number of 
normal control end plates that could be seen was reduced 
to about one third its original value, while the number 
of dystrophic end plates was reduced to less than 1/12 
its original value (Table 1). Those remaining were light 
and difficult to see. 
In the cryostat sections, the same subjective 
darkness was achieved in normals and dystrophies after 
twenty minute incubations. 
Total inhibition of normal control muscle required 
1x10"^M physostigmine solutions. Histochemical reactions 
occurred at concentrations lower than that, and end plates 
could easily be seen by light microscopy. To inhibit com¬ 
pletely the histochemical reaction in dystrophic muscle, 
however, only a concentration of 1x10”8m physostigmine was 
required, a difference one hundred £old. Histochemical 
reaction occurred in dystrophic muscle at 1x10“9m physo¬ 
stigmine. It was not observed at 1x10“7m. . (Table 2) 
(See photomicrographs) 
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B. Denervated Mice 
The animals that had been denervated showed marked 
muscle atrophy and weakness. The muscle had shrunk to one 
half its normal size. The sciatic nerve was still severed 
and ligated. Microscopically, the muscle fibers were small, 
varied in size and shape, and separated by a marked increase 
in connective tissue. End plates varied in size and shape, 
and were less regular in outline and less darkly stained 
(See photomicrographs). It only required inhibition con¬ 
centrations of 1x10“% to inhibit the histochemical reaction 
at these end plates. Normals are not inhibited by concen¬ 
trations less than 1x10”%. 
G. Drug Recipient Animals 
After two weeks the histochemical reaction In the 
drug recipient rats was inhibited by concentrations of 
1x10“% physostigmine, whereas In the control rats it was 
not. After eight weeks, however, neither the reaction in 
the drug recipient rats nor the reaction in the controls 
was inhibited by concentrations of 1x10" ,7M physostigmine. 
'The denervated mice after eight weeks did not return 
to normal cholinesterase activity. The histochemical re¬ 
action was inhibited by 1x10"% physostigmine In the de¬ 
nervated non-drug recipient mice. It was not inhibited in 
normal controls until a concentration of 1x10“% physo¬ 
stigmine was reached. This difference of 1000 fold could 
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not be accounted for by a weight difference of one half. 
In the denervated drug recipient animals, no cholinester¬ 
ase could be stained, even in the absene of inhibitor. 
In con-denervated drug recipient animals the reaction was 
inhibited by lxlO”^M physostigmine concentrations, but not 
by 1x10~8M. 
IV. CONCLUSIONS 
A. Dystrophic Animals 
The histopathological changes in the dystrophic 
animals are exactly similar to the ones noted by Michelson, 
Russell, and Harman, and described earlier. However, the 
histochemical ones shown have not been described. 'There 
are two populations of end plates in the dystrophic mus¬ 
cle: one of normal size and one whose average size Is 
2.1 times normal. The larger end plates are fewer in num¬ 
ber. This correlates well with the variation in muscle 
fiber size, and is probably a reflection of early disin¬ 
tegration of fibers and end plates. However, since immature 
end plates are often larger than normal, this size varia¬ 
tion could be a reflection of lack of normal development 
in these end plates. 
The fact that more time in the reaction solution is 
required to achieve the same degree of reaction in dystro¬ 
phies as in normals is explainable in two different ways: 
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either there is less acetylcholinesterase present in the 
dystrophic end plate or there is a decreased turnover num¬ 
ber of the enzyme in the dystrophic animal. It is hard to 
explain why the enzyme, which is similar to normal enzyme 
in many other ways should have a decreased turnover number 
or rate of reaction. Evidence for the hypothesis that 
there is less enzyme at the dystrophic end plate is found 
in the inhibition studies. Since the inhibitor is a com¬ 
petitive one, if substrate and inhibitor concentration are 
held constant, the amount of reaction is a reflection of 
enzyme activity. The difference of 100 times in amount 
of physostigmine required to inhibit the reaction in dys¬ 
trophic muscle is best explained by a reduction of enzyme 
activity to l/lOO normal in the dystrophic animals. This 
difference cannot be accounted for on a weight basis. A 
reduction in acetylcholinesterase activity at the motor 
end plate in dystrophic animals correlates well with re¬ 
sults reported earlier. If not enough enzyme is present 
to destroy the acetylcholine produced with motor nerve sti¬ 
mulation, tetanic contractions will be produced, as they 
have been. The increased excitability and multiple action 
potentials reported could also be accounted for by a de¬ 
crease in enzyme concentration. This is also true for the 
increased decay constant of the miniature end plate poten¬ 
tial. Certainly the increased sensitivity to neostigmine 
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and the resistance to curare reported "by Baker are ex¬ 
plainable by a decrease in acetylcholinesterase concen¬ 
tration. These studies indicate that a disease process 
is occurring at the motor end plate in dystrophic mice. 
There is both anatomic and biochemical degrangement. 
B. Drug Recipient and Denervated Mice 
The studies in the denervated and drug recipient 
mice are of a preliminary nature. However, the experi¬ 
ments using drug recipient rats indicate that for some 
weeks after chronic anticholinesterase administration, 
the amount of acetylcholinesterase as determined by his- 
tochemical methods is less than normal. However, after 
eight weeks of administration, the amount seems to have 
returned to normal levels. This is interesting in light 
of the fact that in patients with myasthenia gravis who 
are receiving anticholinesterase medications, dosages 
often need to increased after short term chronic adminis¬ 
tration to obtain the same clinical effect. The remaining 
question is that of how inhibition of enzyme activity leads 
to the production of increased enzyme activity. 
The denervated animals show derangement of end 
plate structure as well as decrease in enzyme concentration 
as evidenced by the fact that inhibition requires l/lOOO 
the concentration of inhibitor that normals do. This was 
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true up to eight weeks after denervation, the length of 
time these animals were studied. The denervated animals 
who received anticholinesterase medication, unlike the 
non-denervated animals, were unable to return to the ori¬ 
ginal levels of enzyme activity. It appears that an in¬ 
tact nerve is necessary for the production of acetyl¬ 
cholinesterase. The denervated animals are more vulnerable 
to the actions of anticholinesterase drugs. 
V. SUMMARY 
The acetylcholinesterase activity at the motor end 
plate of dystrophic muscle, denervated muscle, and anti¬ 
cholinesterase-treated muscle was studied histochemically 
using the thioacetic acid technique. Inhibition studies 
using varying concentrations physostigmine salicylate, a 
competitive inhibitor. 
1. The dystrophic muscle was found to have two 
populations of end plates: one of normal size 
and one of over twice normal size. 
2. More time was required to complete the reac¬ 
tion in dystrophic muscle and less inhibitor 
required to inhibit the reaction in dystrophic 
muscle, indicating a decrease in enzyme acti¬ 
vity. The difference in inhibitor concentra¬ 
tion was 100 fold. 
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3. The drug treated animals were found to have 
decreased enzyme activity for a short time 
after treatment was begun; they returned to 
normal activity after eight weeks, indicating 
some form of regeneration of enzyme activity. 
4. Denervated animals were found to have 1/1000 
the enzyme activity eight weeks after nerve 
section. 
5. In denervated animals receiving anticholin¬ 
esterase drugs for eight weeks, no enzyme 
activity could he seen. 
916*r sl^urin/t fcG- sei. 3^^-- ef:X 
aXs 'ifiXX.fi yXXvXoop Xfiin.> 
. u O.:. 3 
Sfilfixas 
•; a b Iuo0 v X i vXXop . 
A
/U
ft
0
E
ft
 
O
F
 
F
N
D
P
/-
A
T
E
5
 
WtfmJ- $ 
£>y S'TEPO F///£ 5 
'30- 
F/o.r 

Table 1 
Piiysostigmine Salicylate lxlO”^Molar 
Muscle No. Sections No. Endplates Endplates/Section 
Dystrophic Inhibited 14 48 3.4 
Dystrophic Uninhibited 13 552 42.4 
Control Inhibited 13 287 22.0 
Control Uninhibited 10 650 65.0 
o1. 5 ' . ' 
j 1:1 dal cxdqoid-s 
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Table 2 
Physostigmine Salicylate 
Concentration Dystrophic Muscle Normal Muscle 
1x10-% 
1x10"7m 
1x10"yM 
1x10"9m 
Inhibited 
Inhibited 
Inhibited 
Not Inhibited 
Inhibited 
Not Inhibited 
Not Inhibited 
Not Inhibited 
:.;d“01xl 
c'.’.-l'. Jc . • ~ lx I 
lb~01xl 
1c h -I ^o:.. :k:"oixi 
Table 3 
Physostigmine 
Concentration Control Denervated, Drug 
1x10”% 
1x10"% 
1x10“% 
1x10"% 
Ho Inhibitor 
Inhibited 
Hot Inhibited 
Hot Inhibited 
Hot Inhibited 
Hot Inhibited 
Inhibited 
Inhibited 
Inhibited 
Inhibited 
Inhibited 
Hon Denervated, Drug Denervated, Ho Drug 
Inhibited 
Inhibited 
Hot Inhibited 
Hot Inhibited 
Hot Inhibited 
Inhibited 
Inhibited 
Inhibited 
Hot Inhibited 
Hot Inhibited 
i: 2 o 
,:o~01:z £ 
ziS-oixi 
Photomicrograph 1. Dystrophic muscle, no inhibitor. Note coagulation 
necrosis, nuclear rowing, increased connective tissue, round cell 
infiltrate, and "moth eaten" endplates. 125x. 
Photomicrograph 2. Dystrophic muscle, no inhibitor. 240x 

Photomicrograph 3. Dystrophic muscle, 1x10“% physostigmine. No 
reaction is seen, 125x. 
Photomicrograph 4* Dystrophic control muscle, 1x10"%. physostigmine. 
Reaction has occurred. Typical dystrophic lesions are absent from 
control. 125x. 
. 
Photomicrograph 5* Dystrophic muscle, 1x10“^M. physostigmine. No 
reaction has occurred. 125x 
Photomicrograph 0. Dystrophic control muscle, 1x1 physostigmine. 
No reaction has occurred. 125x 
* 
4* 
Photomicrograph 7* Normal mouse muscle, 1x10 physostigmine. 125x 
Photomicrograph 8. Denervated mouse muscle, no inhibitor* Note 
atrophy, variation in fiber size, and partially destroyed endplate. 440x. 
* 
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